The test uses the company's SIA platform, a protein biomarker technology that measures different protein isoform populations to assess patient disease states.
Along with scientists from the University of Leicester, the researchers picked the Xevo TQ-S micro platform to do a pilot study on heart failure patient samples.
Taxonomer uses nucleotide and protein information to detect and classify pathogens in clinical samples more accurately and faster than methods like Kraken and SURPI
The test, which uses melt curve analysis and runs on a fully integrated platform from Zeesan, may have a head start on MDR and XDR tests from other companies.
The study found that ctDNA and tissue testing can fail to match up in many cases, but supports independent and complementary value for the two methods.
In Science this week: CRISPR-based barcodes to trace cell lineages, and more.
The director of the National Institutes of Health Francis Collins sang the national anthem this week before a baseball game.
French researchers criticize unexpected government plan to cut research funding, ScienceInsider reports.
In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.